Roche's fat-burning drug shows promise for diabetes

12/14/2011 | Bloomberg

Roche Holding's experimental fat-burning drug helped lower blood glucose levels for 30 days and induce a 10% weight reduction in mice with diabetes, a study in Science Translational Medicine revealed. The drug also helped activate calorie-burning brown fats, increase energy spending and decrease liver fat, researchers said.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President - Government Products
Health Alliance Plan
Detroit, MI
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC